Affiliation:
1. Pacific state medical university
2. NRC Institute of Immunology FMBA of Russia
Abstract
This article discusses issues of clinical diagnosis and course of bronchial asthma in children. We discuss assessment of asthma severity and, accordingly, the extent of the step-by-step therapy according to updated recommendations (GINA 2018). Particular attention is paid to the possibility of improving the control of asthma with the help of the M-cholinolytic drug of long-acting tiotropium bromide, presented as a special inhalation form of tiotropium Respimat and registered in the Russian Federation for treatment of asthma in children of moderate and severe course from 6 years of age. Application tiotropium Respimat in children with insufficient control of asthma allows to improve lung function and asthma control.
Reference29 articles.
1. Pijnenburg M, Karin C. Lodrup Carlsen. Bronchial asthma. ERS Handbook: Paediatric Respiratory Medicine, 2013: 316-27.
2. Global Strategy for Asthma Management and Prevention. Revised 2018. www.ginasthma.com Ссылка активна на 06.09.2017.
3. The federal guidelines for the diagnosis and treatment of bronchial asthma. 2016. www.pulmonology.ru
4. Chuchalin AG, Khaltaev N, Antonov N. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federations. International Journal of COPD, 2014, 9: 963-974. doi: 10.2147/COPD.S67283.
5. National program “Bronchial asthma in children. The strategy for the prevention and treatment” 5th ed., revised and enlarged. M.: Original-maket, 2017. 160 p.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献